Humana Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Humana Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 6324 — Hospital & Medical Service Plans
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Louisville
- Headquarters state / province
- Kentucky
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- HUM
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000049071
- EIN
- 61-0647538
Board of directors
-
Brad D. Smith · DirectorSince 2023
-
Bruce D. Broussard · Director · Chief Executive OfficerSince 2023
-
David A. Jr/Ky Jones · DirectorSince 2023
-
David T. Feinberg · DirectorSince 2023
-
Frank A. Damelio · DirectorSince 2023
-
Frederick John Crawford · DirectorSince 2026
-
Gordon Smith · DirectorSince 2024
-
James J. /Ky Obrien · DirectorSince 2023
-
John W. Garratt · DirectorSince 2023
-
Jorge S. Mesquita · DirectorSince 2023
-
Karen Katz · DirectorSince 2023
-
Kurt J. Hilzinger · DirectorSince 2023
-
Marcy S. Klevorn · DirectorSince 2023
-
Paul John Smith · DirectorSince 2026
-
Raquel C. Bono · DirectorSince 2023
-
Robert Stuart Field · DirectorSince 2026
-
Wayne A.i. Frederick · DirectorSince 2023
-
William J. McDonald · DirectorSince 2023
Chief executives
Bruce D. Broussard
· President & CEO
Dates unknown
Director election results
Annual meeting of April 16, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
83.4%
-
95.0%
-
96.1%
-
97.3%
-
98.9%
-
99.0%
-
99.2%
-
99.2%
-
99.3%
Board connections
12 of this board's directors also sit on 26 other boards.
- via James J. /Ky Obrien
- via Brad D. Smith
- via Marcy S. Klevorn
- via Gordon Smith
- via Gordon Smith
- via John W. Garratt
- via David T. Feinberg
- via James J. /Ky Obrien
- via David T. Feinberg
- via Bruce D. Broussard
- via Frank A. Damelio
- via Wayne A.i. Frederick
- via Brad D. Smith
- via Brad D. Smith
- via Bruce D. Broussard
- via Jorge S. Mesquita
- via Marcy S. Klevorn
- via Kurt J. Hilzinger
- via John W. Garratt
- via Bruce D. Broussard
- via Wayne A.i. Frederick
- via Karen Katz
- via Karen Katz
- via Frank A. Damelio
- via Wayne A.i. Frederick
- via Frank A. Damelio
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $150,020
- 1 purchase by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 1, 2026 | Nundy Shantanu Officer (Chief Medical Officer) | Grant or award | +2,549 | — | — |
| Aug 1, 2026 | Frederick John Crawford Director | Grant or award | +544 | — | — |
| Aug 1, 2026 | Paul John Smith Director | Grant or award | +544 | — | — |
| May 1, 2026 | Mellet Celeste Officer (Chief Financial Officer) | Grant or award | −15,387 | — | — |
| May 1, 2026 | Mehta Japan Officer (Chief Information Officer) | Grant or award | +9,448 | — | — |
| May 1, 2026 | Dintenfass David Officer (President, Enterprise Growth) | Grant or award | +11,273 | — | — |
| May 1, 2026 | Rechtin James A. Officer (President & CEO) | Grant or award | +35,633 | — | — |
| May 1, 2026 | Michelle A. O'Hara Officer (Chief Human Resources Officer) | Grant or award | +10,485 | — | — |
| May 1, 2026 | Robert Stuart Field Director | Grant or award | +852 | — | — |
| May 1, 2026 | Ventura Joseph C Officer (Chief Legal Officer) | Grant or award | +10,318 | — | — |
| May 1, 2026 | Shetty Sanjay K Officer (President, CenterWell) | Grant or award | +9,945 | — | — |
| May 1, 2026 | Martin Aaron Officer (President, Medicare Advantage) | Grant or award | +8,206 | — | — |
| Apr 1, 2026 | Shetty Sanjay K Officer (President, CenterWell) | Option exercise | +887 | — | — |
| Apr 1, 2026 | Shetty Sanjay K Officer (President, CenterWell) | Shares withheld for tax | −401 | $175.44 | $70,351 |
| Feb 24, 2026 | Ventura Joseph C Officer (Chief Legal Officer) | Option exercise | +1,035 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.